LifeMD annual gross margin
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
LifeMD's gross margin was 85.72% for fiscal 2025.
View full LifeMD company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 85.72% | −0.43 pp |
| 2024 | 2024-12-31 | 86.15% | −1.46 pp |
| 2023 | 2023-12-31 | 87.61% | +3.29 pp |
| 2022 | 2022-12-31 | 84.32% | +3.69 pp |
| 2021 | 2021-12-31 | 80.62% | +4.38 pp |
| 2020 | 2020-12-31 | 76.24% | −3.51 pp |
| 2019 | 2019-12-31 | 79.75% | −14804.19 pp |
| 2018 | 2018-12-31 | 14,883.94% | +3401.39 pp |
| 2017 | 2017-12-31 | 11,482.55% | +11419.70 pp |
| 2016 | 2016-12-31 | 62.85% | −16.82 pp |
| 2015 | 2015-12-31 | 79.67% | +3.88 pp |
| 2014 | 2014-12-31 | 75.80% | −1.77 pp |
| 2013 | 2013-12-31 | 77.57% | +7.24 pp |
| 2012 | 2012-12-31 | 70.33% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 88.82% | +2.77 pp |
| Q1 2026 | 2026-03-31 | 88.19% | +4.18 pp |
| Q4 2025 | 2025-12-31 | 84.31% | +85.14 pp |
| Q3 2025 | 2025-09-30 | 87.69% | −2.90 pp |
| Q2 2025 | 2025-06-30 | 86.05% | −4.03 pp |
| Q1 2025 | 2025-03-31 | 84.01% | −5.57 pp |
| Q4 2024 | 2024-12-31 | −0.84% | −88.90 pp |
| Q3 2024 | 2024-09-30 | 90.59% | +2.97 pp |
| Q2 2024 | 2024-06-30 | 90.08% | +2.73 pp |
| Q1 2024 | 2024-03-31 | 89.58% | +2.30 pp |
| Q4 2023 | 2023-12-31 | 88.06% | +2.53 pp |
| Q3 2023 | 2023-09-30 | 87.62% | +2.63 pp |
| Q2 2023 | 2023-06-30 | 87.35% | +2.57 pp |
| Q1 2023 | 2023-03-31 | 87.28% | +5.35 pp |
| Q4 2022 | 2022-12-31 | 85.53% | +5.84 pp |
| Q3 2022 | 2022-09-30 | 84.98% | +5.41 pp |
| Q2 2022 | 2022-06-30 | 84.78% | +3.25 pp |
| Q1 2022 | 2022-03-31 | 81.93% | −0.43 pp |
| Q4 2021 | 2021-12-31 | 79.69% | +11.91 pp |
| Q3 2021 | 2021-09-30 | 79.57% | −5.20 pp |
| Q2 2021 | 2021-06-30 | 81.53% | +0.18 pp |
| Q1 2021 | 2021-03-31 | 82.35% | +13.43 pp |
| Q4 2020 | 2020-12-31 | 67.79% | −20.11 pp |
| Q3 2020 | 2020-09-30 | 84.78% | +6.53 pp |
| Q2 2020 | 2020-06-30 | 81.36% | +5.64 pp |
| Q1 2020 | 2020-03-31 | 68.93% | −4.68 pp |
| Q4 2019 | 2019-12-31 | 87.89% | +5.51 pp |
| Q3 2019 | 2019-09-30 | 78.25% | +4.49 pp |
| Q2 2019 | 2019-06-30 | 75.72% | −2.16 pp |
| Q1 2019 | 2019-03-31 | 73.60% | −0.29 pp |
| Q3 2018 | 2018-09-30 | 82.38% | +10.42 pp |
| Q2 2018 | 2018-06-30 | 73.76% | +26.27 pp |
| Q1 2018 | 2018-03-31 | 77.87% | −70.92 pp |
| Q3 2017 | 2017-09-30 | 73.90% | +1.94 pp |
| Q2 2017 | 2017-06-30 | 71.96% | +29.08 pp |
| Q1 2017 | 2017-03-31 | 47.48% | +29.02 pp |
| Q4 2016 | 2016-12-31 | 148.79% | +51.49 pp |
| Q3 2016 | 2016-09-30 | 71.96% | −1.61 pp |
| Q2 2016 | 2016-06-30 | 42.88% | −24.85 pp |
| Q1 2016 | 2016-03-31 | 18.47% | −55.79 pp |
| Q4 2015 | 2015-12-31 | 97.30% | −13.34 pp |
| Q3 2015 | 2015-09-30 | 73.56% | +16.84 pp |
| Q2 2015 | 2015-06-30 | 67.73% | +2.90 pp |
| Q1 2015 | 2015-03-31 | 74.26% | −0.23 pp |
| Q4 2014 | 2014-12-31 | 110.65% | +23.34 pp |
| Q3 2014 | 2014-09-30 | 56.73% | +1.48 pp |
| Q2 2014 | 2014-06-30 | 64.83% | −14.84 pp |
| Q1 2014 | 2014-03-31 | 74.49% | −2.54 pp |
| Q4 2013 | 2013-12-31 | 87.31% | −1.72 pp |
| Q3 2013 | 2013-09-30 | 55.25% | −9.35 pp |
| Q2 2013 | 2013-06-30 | 79.66% | +25.28 pp |
| Q1 2013 | 2013-03-31 | 77.03% | −6.41 pp |
| Q4 2012 | 2012-12-31 | 89.03% | — |
| Q3 2012 | 2012-09-30 | 64.60% | — |
| Q2 2012 | 2012-06-30 | 54.39% | — |
| Q1 2012 | 2012-03-31 | 83.44% | — |
Over the last five reported fiscal years, LifeMD's gross margin increased from 76.24% to 85.72%, a change of +9.48 percentage points. The latest reported quarter, Q2 2026, shows 88.82%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LifeMD filings at SEC.gov ↗